450
Participants
Start Date
March 31, 2001
Study Completion Date
October 31, 2004
Olanzapine
Quetiapine
Risperidone
Citalopram
Mount Sinai School of Medicine, New York
Columbia University, New York
Staten Island University Hospital, Staten Island
Monroe Community Hospital, Rochester
Global Research and Consulting, Olean
Mental Illness Research Education and Clinical Center, Philadelphia
VA Medical Center, Coatesville
Johns Hopkins University, Baltimore
Wake Forest University School of Medicine, Winston-Salem
Duke University Medical Center, Durham
Medical University of South Carolina, North Charleston
Emory University - Wesley Woods Health Center, Atlanta
Berma Research Group, Hialeah
Palm Beach Neurology/Premiere Research Institute, West Palm Beach
Mental Health Advocates, Inc., Boca Raton
University of South Florida Suncoast Gerontology Center, Tampa
Tuscaloosa VA Medical Center, Tuscaloosa
University Hospital Health Systems-Laurelwood Hospital, Willoughby
University of Iowa College of Medicine, Iowa City
Northwestern University Medical School, Chicago
Southern Illinois School of Medicine, Springfield
Millennium Psychiatric Associates, St Louis
Louisiana State University Health Sciences Center, Shreveport
University of Southern California Dept of Psychiatry& Behavioral Sciences, Los Angeles
University of California, Los Angeles, VA Medical Center, Los Angeles
University of California-San Diego, VA Medical Center, San Diego
University of California, Irvine Medical Center, Irvine
Stanford University School of Medicine, Stanford
University of Hawaii, Honolulu
Yale University School of Medicine, New Haven
University of Medicine and Dentistry of New Jersey, Piscataway
University of Medicine and Dentistry of New Jersey-Stratford, Stratford
University of Texas Southwestern Medical Center, Dallas
Southwestern Vermont Medical Center- The Memory Clinic, Bennington
National Institute of Mental Health (NIMH)
NIH